pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 16·1 min read
save

US spends $360,000 storing contraceptives meant for African aid, with most supplies nearing expiration

Jun 16, 2026·read at STAT ↗Neutral

The U.S. government spent roughly $360,000 between January 2025 and March 2026 to keep millions of dollars worth of contraceptives in climate-controlled storage, according to a recent USAID Office of Inspector General advisory. The monthly cost rose from about $17,000 to $24,000 during that period.

The birth control kits were originally destined for low-income countries in Africa, but after significant cuts to USAID under the previous administration they remained in Belgium instead of being shipped abroad.

Out of the $9.7 million in family-planning supplies, only about $1.7 million are still usable, and many of the products face expiration dates beginning in April 2028.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “How supplement use changed over decades”

read at STAT ↗
1,137 words · retrieved Jun 16
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Anti-inflammatoryZINC
topics
Obesity4Immunology2Psychiatry & CNS2CardiologyGLP-1 receptorHematologyVaccines

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Aug 12Opinion: Climate change is making people with chronic illness even sickerSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 19h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Aug 26Newer shingles vaccine linked to lower heart disease risk, ‘natural experiment’ showsSTAT